Sumitomo Pharma Co., Ltd.

Japan · Reporting entity ID 100000010437

Total reported 2019–2025

$17.3M

#354 of 2,960 reporting companies — 0% of all reported industry payments

$6.97M in general payments across 613 records, plus $10.3M in research funding across 50 records.

How it breaks down

General payments $6,971,209

Research funding $10,345,921

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.